Medtech’s Shocking Profit Potential
Cancer has been a burden on millions around the world.
Medically, we’ve come a long way from the ’80s and ’90s when there were just a few treatment options — drugs, radiation or surgery.
Since then, science and medicine have evolved, developing new, groundbreaking treatments that are less and less invasive.
It’s incredible how far we’ve come, and nobody appreciates it more than I do.
I’m a Survivor Too
As a cancer survivor myself, I know how important these advancements are…
You see, I was diagnosed with non-Hodgkin’s lymphoma back in 1991. In those days I was given two treatment options. If one or the other didn’t work, then there was nothing medically that could be done to save my life.
I was one of the fortunate ones and the treatment worked! And I’ve been in remission ever since.
I share my personal story with you because I’ve personally witnessed and experienced the frailty or lack of treatment options for the many variations of the disease.
In a similar way I’ve also seen medical technology progress throughout the years…
That’s led me to track, report on and correctly predict the most promising medical technologies before any mainstream source covers it.
Cancer isn’t a single disease — and even the same cancer type can behave very differently among individuals.
There’s a good reason for that. We are each genetically unique, and because cancer comes from our own cells gone awry, the disease itself is unique too.
Which is why medical technology has been uniquely transforming the way we treat cancer…
Introducing: the Electroceutical Revolution — a transformative Medtech that’s elevating Big Pharma and health care.
While many cancer drug developers work on drug-based treatments, electroceutical technology creates a unique modality for the treatment of cancer beyond traditional therapies — surgery, ionizing radiation and drugs, for instance.
The process uses electrical fields as a way to selectively attack cancer cells. Cell DNA is sensitive to electrical fields, particularly during cell division, and this vulnerability allows the electroceutical devices to alter the electric field in the cell’s electrical charges.
Clinical studies so far have shown patients who added an electroceutical device to their chemotherapy had a higher chance of living longer than those receiving chemotherapy alone.
The developments in this technology are quite new and I’m still in the midst of significant research. That said, this technology seems very promising.
That’s why you come to Tech Profits Daily to find the next big thing in tech and biotech, before it hits the mainstream.
As opportunity arises from this new path in cancer therapies I’ll be right back here with more actionable ideas to profit on.
For Technology Profits Daily,
Chief Technology Expert, Technology Profits Daily